Alternating Combination Chemotherapy COP (Cyclophosphamide, Vincristine, Prednisone) and MP (Melphalan, Prednisone) in Multiple Myeloma: a Multicenter Phase II Study (JCOG8906)-Reference-Cited by-同舟云学术

Alternating Combination Chemotherapy COP (Cyclophosphamide, Vincristine, Prednisone) and MP (Melphalan, Prednisone) in Multiple Myeloma: a Multicenter Phase II Study (JCOG8906)

Published:1999-10-01 Issue:10 Volume:29 Page:485-489
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:Japanese Journal of Clinical Oncology

Author:

Takenaka T.,Shirakawa S.,Mikuni C.,Sai T.,Shimamoto Y.,Araki K.,Hirano M.,Miura A.,Ohno Y.-i.,Ichimaru M.,Hanada S.-i.,Inaba S.,Konishi H.,Toki H.,Tajima K.,Niimi M.,Fukuda H.,Shimoyama M.,

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/29/10/485/5397232/29-10-485.pdf

Reference33 articles.

1. Treatment for Multiple Myeloma

2. Chemotherapy of myeloma: Drug combinations versus single agents, an overview, and comments on acute leukemia in myeloma

3. Controversies in the treatment of plasma cell myeloma.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coexistence of primary colorectal follicular lymphoma and multiple myeloma: a case report;International Journal of General Medicine;2018-09

2. Lymphoma Study Group of JCOG;Japanese Journal of Clinical Oncology;2011-12-06

3. Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301;International Journal of Hematology;2004-02-01